Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging
| Autor: | Katja Pinker, Fleur Kilburn-Toppin, Tamar Sella, Sophia Zackrisson, A. Athanasiou, Francesco Sardanelli, Karen Kinkel, Ulrich Bick, Mihai Lesaru, Maria Bernathova, Chantal Van Ongeval, Christiane K. Kuhl, Federica Pediconi, Boris Brkljačić, Corinne Balleyguier, Laura Martincich, Eva M. Fallenberg, Anne Tardivon, Gul Esen, Julia Camps Herrero, Catherine Colin, Paola Clauser, Michel Herranz, Matthew G. Wallis, Pietro Panizza, Krisztina Borbély, Ruud M. Pijnappel, Michael H. Fuchsjaeger, Pascal A. T. Baltzer, Simone Schiaffino, Andrew Evans, Gabor Forrai, Rubina M. Trimboli, Marc B. I. Lobbes, Isabelle Thomassin-Naggara, Luca Alessandro Carbonaro, Enrico Cassano, S H Heywang-Köbrunner, Thomas H. Helbich, Fiona J. Gilbert, Ritse M. Mann |
|---|---|
| Přispěvatelé: | Sardanelli, Francesco [0000-0001-6545-9427], Apollo - University of Cambridge Repository, Acibadem University Dspace |
| Rok vydání: | 2020 |
| Předmět: |
Breast biopsy
lcsh:Medical physics. Medical radiology. Nuclear medicine medicine.medical_specialty WIRE LOCALIZATION Stereotactic biopsy CORE-NEEDLE-BIOPSY Breast imaging lcsh:R895-920 ComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISION Guideline 030218 nuclear medicine & medical imaging 2ND-LOOK ULTRASOUND 03 medical and health sciences 0302 clinical medicine All institutes and research themes of the Radboud University Medical Center Breast lesion localisation breast biopsy imaging Biopsy Fine-needle sampling medicine MALIGNANT POTENTIAL B3 Mammography EUSOBI RECOMMENDATIONS Radiology Nuclear Medicine and imaging Sampling (medicine) DIAGNOSTIC-ACCURACY Breast ASPIRATION-CYTOLOGY Science & Technology medicine.diagnostic_test business.industry Radiology Nuclear Medicine & Medical Imaging RADIOACTIVE SEED LOCALIZATION 3. Good health Women's cancers Radboud Institute for Health Sciences [Radboudumc 17] LYMPH-NODE BIOPSY percutaneous biopsy imaging guidance mammography tomosynthesis magnetic resonance imaging Vacuum-assisted biopsy 030220 oncology & carcinogenesis Vacuum-Assisted Biopsy LESION EXCISION SYSTEM Core needle biopsy Radiology business Image-Guided Biopsy Life Sciences & Biomedicine |
| Zdroj: | Insights into Imaging, Vol 11, Iss 1, Pp 1-18 (2020) Insights into Imaging Insights Into Imaging, 11, 1 Insights Into Imaging, 11 |
| ISSN: | 1869-4101 |
| Popis: | We summarise here the information to be provided to women and referring physicians about percutaneous breast biopsy and lesion localisation under imaging guidance. After explaining why a preoperative diagnosis with a percutaneous biopsy is preferred to surgical biopsy, we illustrate the criteria used by radiologists for choosing the most appropriate combination of device type for sampling and imaging technique for guidance. Then, we describe the commonly used devices, from fine-needle sampling to tissue biopsy with larger needles, namely core needle biopsy and vacuum-assisted biopsy, and how mammography, digital breast tomosynthesis, ultrasound, or magnetic resonance imaging work for targeting the lesion for sampling or localisation. The differences among the techniques available for localisation (carbon marking, metallic wire, radiotracer injection, radioactive seed, and magnetic seed localisation) are illustrated. Type and rate of possible complications are described and the issue of concomitant antiplatelet or anticoagulant therapy is also addressed. The importance of pathological-radiological correlation is highlighted: when evaluating the results of any needle sampling, the radiologist must check the concordance between the cytology/pathology report of the sample and the radiological appearance of the biopsied lesion. We recommend that special attention is paid to a proper and tactful approach when communicating to the woman the need for tissue sampling as well as the possibility of cancer diagnosis, repeat tissue sampling, and or even surgery when tissue sampling shows a lesion with uncertain malignant potential (also referred to as “high-risk” or B3 lesions). Finally, seven frequently asked questions are answered. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink